REQUEST A DEMO
Total
USD $0.00
Search more companies

Tium Bio Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing | Scientific Research and Development Services
Full name: Tium Bio Co.,Ltd. Profile Updated: December 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Tium Bio Co.,Ltd. is an enterprise located in South Korea, with the main office in Seongnam. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on December 06, 2016. It currently has a total number of 64 (2024) employees. There was a net sales revenue increase of 47.66% reported in Tium Bio Co.,Ltd.’s latest financial highlights for Q3C2025. There was a total growth of 9.64% in Tium Bio Co.,Ltd.’s total assets over the same period. In, 2025, the company’s net profit margin increased by 288.82%.

Headquarters
4th Floor, 49, Daewangpangyo-ro 644beon-gil Bundang-gu Seongnam-si Gyeonggi
Seongnam; Gyeonggi;

Contact Details: Purchase the Tium Bio Co.,Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Tium Bio Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Tium Bio Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Tium Bio Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Tium Bio Co.,Ltd. report to view the information.
Incorporation Date:
December 06, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Auditor
Subsidiaries
Initium Therapeutics, Inc (United States)
100%
Company Performance
Financial values in the chart are available after Tium Bio Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
47.66%
Total Operating Revenue
33.58%
Operating Profit
-3.81%
EBITDA
-4.93%
Net Profit/Loss for the Period
37.8%
Total Assets
9.64%
Total Equity
-18.8%
Operating Profit Margin
70.89%
Net Profit Margin
288.82%
Return on Equity (ROE)
14.05%
Debt / Equity
51.29%
Quick Ratio
0.16%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?